HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M)
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M) trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to beat throat cancer without removing the voice box
Disease control Recruiting nowThis study tests a combination of chemotherapy drugs (carboplatin or cisplatin, paclitaxel) and an immunotherapy drug (toripalimab) in adults with advanced throat cancer that has come back or spread. The goal is to see if this treatment can control the cancer and help patients av…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M)
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New hope for kids with relapsed cancers: targeted drug trial opens
Disease control Recruiting nowThis study tests a new drug called Becotatug Vedotin in children aged 2 to 18 with certain cancers (like head and neck, brain, or kidney tumors) that have come back or spread. The drug targets a protein called EGFR found on many cancer cells. The main goal is to see if the drug i…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M)
Phase: PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 18, 2026 11:58 UTC